Literature DB >> 9686957

Renal biopsy diagnosis in children presenting with haematuria.

A I Piqueras1, R H White, F Raafat, N Moghal, D V Milford.   

Abstract

We reviewed the clinical and renal biopsy findings in 322 children presenting during the years 1975-1996 with recurrent macro- or continuous microscopic haematuria persisting for > or =6 months, in whom non-glomerular causes were excluded. Family involvement was documented for first-degree relatives. All biopsies were examined by light microscopy, 317 by electron microscopy and 315 by immunofluorescence. Biopsies were classified as IgA nephropathy (78), Alport nephropathy (86), thin basement membrane nephropathy (TMN) (50), miscellaneous glomerulonephritis (32), hilar vasculopathy (28) and normal glomeruli (48). Although microscopic haematuria alone was more frequent in Alport nephropathy and TMN, the pattern of haematuria in individual patients did not predict histology. Of patients with familial haematuria, 79% of biopsies showed either Alport nephropathy or TMN. Hilar vasculopathy was observed both in isolation and in all abnormal histological categories.

Entities:  

Mesh:

Year:  1998        PMID: 9686957     DOI: 10.1007/s004670050471

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

1.  Native kidney biopsies in Armenian and Swiss children: high prevalence of amyloidosis in Yerevan and of IgA nephropathy in Zurich.

Authors:  Guido F Laube; Ashot Sarkissian; Helen Nazaryan; Giuseppina Spartà; Armen Sanamyan; Ara Babloyan; Ernst Leumann; Ariana Gaspert
Journal:  Virchows Arch       Date:  2014-11-08       Impact factor: 4.064

2.  The Alport nephropathy: clinicopathological correlations.

Authors:  Richard H R White; Faro Raafat; David V Milford; Filadelfia Komianou; Nadeem E Moghal
Journal:  Pediatr Nephrol       Date:  2005-04-26       Impact factor: 3.714

Review 3.  Haematuria as a risk factor for chronic kidney disease progression in glomerular diseases: A review.

Authors:  Juan Antonio Moreno; Claudia Yuste; Eduardo Gutiérrez; Ángel M Sevillano; Alfonso Rubio-Navarro; Juan Manuel Amaro-Villalobos; Manuel Praga; Jesús Egido
Journal:  Pediatr Nephrol       Date:  2015-05-17       Impact factor: 3.714

4.  Childhood thin GBM disease: review of 22 children with family studies and long-term follow-up.

Authors:  Carla Carasi; William G Van't Hoff; Lesley Rees; R Anthony Risdon; Richard S Trompeter; Michael J Dillon
Journal:  Pediatr Nephrol       Date:  2005-06-07       Impact factor: 3.714

5.  Erythrocyte deformability and microhematuria in children and adolescents.

Authors:  Anamarija Meglic; Drago Kuzman; Janez Jazbec; Barbara Japelj-Pavesić; Rajko B Kenda
Journal:  Pediatr Nephrol       Date:  2003-01-17       Impact factor: 3.714

Review 6.  Familial hematuria.

Authors:  Clifford E Kashtan
Journal:  Pediatr Nephrol       Date:  2007-10-02       Impact factor: 3.714

7.  Glomerular diseases in Iranian children: clinico-pathological correlations.

Authors:  Abbas Madani; Daryoush Fahimi; Seid Taher Esfehani; Parvin Mohsseni; Nematollah Atayee; Mahmood Ahmadi; Fatemeh Elmi; Marziyeh Haddadi
Journal:  Pediatr Nephrol       Date:  2003-07-26       Impact factor: 3.714

8.  Urine erythrocyte morphology in patients with microscopic haematuria caused by a glomerulopathy.

Authors:  Giovanni Battista Fogazzi; Alberto Edefonti; Giuseppe Garigali; Marisa Giani; Anna Zolin; Sara Raimondi; Michael J Mihatsch; Piergiorgio Messa
Journal:  Pediatr Nephrol       Date:  2008-03-07       Impact factor: 3.714

Review 9.  Asymptomatic hematuria in childhood: a practical approach to evaluation.

Authors:  E G Wood
Journal:  Indian J Pediatr       Date:  1999 Mar-Apr       Impact factor: 5.319

10.  Diagnostic yield of renal biopsies: a retrospective single center review.

Authors:  Bari Scheckner; Alexandra Peyser; Jacob Rube; Freya Tarapore; Rachel Frank; Suzanne Vento; Cathy Hoffman; Elsa Valderrama; Douglas Charney; Beatrice Goilav; Howard Trachtman
Journal:  BMC Nephrol       Date:  2009-05-21       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.